Repeated remimazolam sedation for interstitial brachytherapy in cervical cancer: a randomized controlled trial.
· Salud
Evidence regarding repeated remimazolam administration remains limited. We hypothesized that remimazolam would be associated with fewer adverse events than propofol while maintaining stable sedative requirements across three repeated sedation sessions. Patients with cervical cancer undergoing three fractions of interstitial brachytherapy were randomized…
Fuente: PubMed — NCBI
Deja un comentario